Neurogene Inc. (NGNE) › Operating IncomeNeurogene Inc. (NGNE) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2016: -$37.65M2017: -$51.12M2018: -$32.62M2019: -$70.96M2020: -$33.73M2021: -$60.70M2022: -$56.52M2023: -$55.58M2024: -$82.61M2025: -$103.33M-$103.33M2016Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$103.33M-25.1%2024-$82.61M-48.6%2023-$55.58M+1.7%2022-$56.52M+6.9%2021-$60.70M-80.0%2020-$33.73M+52.5%2019-$70.96M-117.5%2018-$32.62M+36.2%2017-$51.12M-35.8%2016-$37.65M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share